Biogen (BIIB) Tops Q1 EPS by 12c, Offers Guidance
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $209.03 --0%
Revenue Growth %: -6.5%
Financial Fact:
Total revenues: 2.96B
Today's EPS Names:
CCEL, FNGR, FAST, More
Revenue Growth %: -6.5%
Financial Fact:
Total revenues: 2.96B
Today's EPS Names:
CCEL, FNGR, FAST, More
Join SI Premium – FREE
Biogen (NASDAQ: BIIB) reported Q1 EPS of $3.40, $0.12 better than the analyst estimate of $3.28. Revenue for the quarter came in at $2.46 billion versus the consensus estimate of $2.34 billion.
GUIDANCE:
Biogen sees FY2023 EPS of $15.00-$16.00, versus the consensus of $15.48.
- Total revenue Mid-single digit percentage decline versus reported full year 2022
For earnings history and earnings-related data on Biogen (BIIB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AngioDynamics (ANGO) Tops Q4 EPS by 2c ; Offers Guidance
- Citi on Texas Instruments: We are buyers into earnings
- First Solar (FSLR) PT Raised to $279 at Barclays
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
